<?xml version="1.0" encoding="UTF-8"?>
<p>Acute infection by HEV is characterized from studies of experimentally infected animals by anti-HEV IgM antibodies, followed by the anti-HEV IgG after a few days [
 <xref rid="B51-medicina-56-00206" ref-type="bibr">51</xref>,
 <xref rid="B58-medicina-56-00206" ref-type="bibr">58</xref>,
 <xref rid="B59-medicina-56-00206" ref-type="bibr">59</xref>,
 <xref rid="B60-medicina-56-00206" ref-type="bibr">60</xref>]. Anti-HEV IgM titres decline rapidly during early period of recovery while the IgG antibodies have been detected for periods longer than 14 years and provide protection against subsequent infections [
 <xref rid="B61-medicina-56-00206" ref-type="bibr">61</xref>]. Researchers speculate that it is not feasible to detect the incidence of sporadic hepatitis E accurately and with certainty unless HEV-RNA, IgM, and rising IgG levels are all used as markers of HEV-caused acute hepatitis [
 <xref rid="B54-medicina-56-00206" ref-type="bibr">54</xref>].
</p>
